Heeyeong Cho
Inventor
Stats
- 5 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 5 US Patents Issued
- 10 US Applications Filed
- 13 Total Citation Count
- Oct 12, 2022 Most Recent Filing
- Feb 24, 2005 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| KUKJE PHARM. IND. CO., LTD. | 1
| 2008
|
| SAMSUNG LIFE PUBLIC WELFARE FOUNDATION | 1
| 2015
|
| KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY | 2
2 1 2 2 2 1 | 2005
2007 2008 2009 2012 2014 2015 |
| THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION | 2
| 2014
|
Inventor Addresses
| Address | Duration |
|---|---|
| Daejeon, KR | Oct 18, 07 - Jan 09, 25 |
| Daejun, KR | Mar 29, 11 - Mar 29, 11 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A23L: | FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 9 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0009,742 | 2025 | NOVEL CAPSID ASSEMBLY INHIBITORS | 0 |
| 2022/0009,933 | 2022 | NOVEL TRICYCLIC COMPOUND AS IRAK4 INHIBITOR | 2 |
| 10526337 | 2020 | Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with PI3 kinases, containing same as active ingredient | 0 |
| 2018/0105,527 | 2018 | HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSTION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT | 1 |
| 9650389 | 2017 | 8-oxoprotoberberine derivative or pharmaceutically acceptable salt thereof, preparation method therefor and pharmaceutical composition for preventing or treating diseases associated with activity of NFAT5, containing same as active ingredient | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.